Cargando…
Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler’s diarrhea: a prospective cohort study protocol
BACKGROUND: Acute gastroenteritis (AGE) is the leading cause of illness among returning travelers seeking medical care. Multiple types of enteric pathogens can cause travel-acquired AGE and, while bacterial pathogens have a predominant role, the importance of viruses, such as norovirus, is increasin...
Autores principales: | Lindsay, Lisa, DuPont, Herbert L., Moe, Christine L., Alberer, Martin, Hatz, Christoph, Kirby, Amy E., Wu, Henry M., Verstraeten, Thomas, Steffen, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276235/ https://www.ncbi.nlm.nih.gov/pubmed/30509202 http://dx.doi.org/10.1186/s12879-018-3461-6 |
Ejemplares similares
-
Correction to: Norovirus acute gastroenteritis amongst US and European travellers to areas of moderate to high risk of travellers’ diarrhoea: a prospective cohort study
Publicado: (2023) -
The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009) -
Norovirus: new developments and implications for travelers’ diarrhea
por: Simons, Mark P., et al.
Publicado: (2016) -
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply
por: Steffen, Robert, et al.
Publicado: (2019) -
The Prevalence of Norovirus in returning international travelers with diarrhea
por: Apelt, Nadja, et al.
Publicado: (2010)